✦ LIBER ✦

Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis

✍ Scribed by Hashimoto, N; Iwasaki, T; Sekiguchi, M; Takatsuka, H; Okamoto, T; Hashimoto, T; Sano, H

Book ID: 110014094
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 124 KB
Volume: 33
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704432

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemolytic uremic syndrome after allogene

Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies

✍ Kondo, M; Kojima, S; Horibe, K; Kato, K; Matsuyama, T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Idiopathic pneumonia syndrome after high

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

✍ Wong, R; Rondon, G; Saliba, R M; Shannon, V R; Giralt, S A; Champlin, R E; Ueno, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Prognostic factors for disease progressi

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

✍ Popat, U; Hosing, C; Saliba, R M; Anderlini, P; Besien, K van; Przepiorka, D; Kh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat

Intensive conditioning regimen of etopos

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

✍ Benekli, M; Smiley, S L; Younis, T; Czuczman, M S; Hernandez-Ilizaliturri, F; Ba 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 175 KB

High-dose therapy and autologous hematop

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric hodgkin’s disease: analysis of the stanford university results and prognostic indices

✍ Y.C Lieskovsky; M Torres; R Wong; R Agarwal; M Amylon; S Donaldson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 19 KB